Cancer Institute NSW is seeking legal advice over the continued use of AI mammography software whose ARTG entry was cancelled in June, despite assurances from the TGA that there are no specific safety concerns.
Cancer Institute NSW is seeking legal advice over the continued use of AI mammography software whose ARTG entry was cancelled in June, despite assurances from the TGA that there are no specific safety concerns.
This content is for paid subscribers only.
Start your free trial nowor purchase a monthly or annual subscription to read.